For its “Healthcare AI 2020” report, KLAS analyzed the recent AI purchase decisions of 47 organizations to determine which vendors are being considered and chosen the most for new software and tools.
Here’s what both customers and non-customers said when asked about the perceived strength and weaknesses of the following healthcare AI offerings:
- Microsoft: 13 said strong to very strong; 7 said weak to very weak
- Google: 10 said strong to very strong; 6 said weak to very weak
- Amazon: 10 said strong to very strong; 8 said weak to very weak
- IBM: 9 said strong to very strong; 15 said weak to very weak
Here are the healthcare AI purchase decisions of the organizations analyzed in the report, listed by the number of organizations that chose the following vendors:
- Epic: 12
- Jvion: 8
- DataRobot: 5
- KenSci: 5
- ClosedLoop.ai: 5
- Health Catalyst: 4
- Cerner: 3
- Medial EarlySign: 3
- Microsoft: 2
- IBM: 0
Vendors with low consideration, meaning fewer than four organizations considering purchasing their software, include Google, Dataiku, Dotdata, H20.ai, SAS and Symphony AyasediAI.
More articles on artificial intelligence:
FDA holds public meeting on AI, focuses on data training bias
VA pilots AI tool to predict COVID-19 mortality rates
5 ways machine learning can improve patients’ experience and outcomes
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
